IRIS
MORETTA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60.190
AS - Asia 5.317
NA - Nord America 4.056
Continente sconosciuto - Info sul continente non disponibili 566
SA - Sud America 446
AF - Africa 91
OC - Oceania 4
Totale 70.670
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.215
US - Stati Uniti d'America 3.743
SG - Singapore 2.381
CN - Cina 1.378
VN - Vietnam 828
FR - Francia 494
BR - Brasile 283
BD - Bangladesh 233
HK - Hong Kong 187
CA - Canada 118
FI - Finlandia 109
DE - Germania 95
MX - Messico 75
JP - Giappone 68
CH - Svizzera 66
AR - Argentina 60
GB - Regno Unito 54
IN - India 36
NL - Olanda 34
IQ - Iraq 31
ID - Indonesia 29
PH - Filippine 28
CR - Costa Rica 25
EC - Ecuador 25
JM - Giamaica 23
CO - Colombia 22
ZA - Sudafrica 17
ES - Italia 16
PK - Pakistan 16
RU - Federazione Russa 16
TH - Thailandia 15
GT - Guatemala 14
CL - Cile 13
IE - Irlanda 13
VE - Venezuela 13
HN - Honduras 12
MA - Marocco 12
PY - Paraguay 12
TT - Trinidad e Tobago 11
UZ - Uzbekistan 11
NI - Nicaragua 10
PE - Perù 10
SV - El Salvador 9
DZ - Algeria 8
KE - Kenya 8
PL - Polonia 8
SA - Arabia Saudita 8
UA - Ucraina 8
EG - Egitto 7
MY - Malesia 7
PR - Porto Rico 7
RO - Romania 7
TW - Taiwan 7
BG - Bulgaria 6
JO - Giordania 6
PT - Portogallo 6
TN - Tunisia 6
AL - Albania 5
AT - Austria 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
GA - Gabon 4
IR - Iran 4
NP - Nepal 4
OM - Oman 4
PS - Palestinian Territory 4
SC - Seychelles 4
SN - Senegal 4
TR - Turchia 4
AU - Australia 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
LB - Libano 3
MM - Myanmar 3
BE - Belgio 2
CD - Congo 2
CG - Congo 2
CI - Costa d'Avorio 2
DJ - Gibuti 2
ET - Etiopia 2
GF - Guiana Francese 2
GR - Grecia 2
IL - Israele 2
KG - Kirghizistan 2
LT - Lituania 2
ML - Mali 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
TL - Timor Orientale 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 70.080
Salva come PNG Salva come JPEG
Città #
Genova 40.047
Genoa 10.851
Rapallo 4.521
Vado Ligure 3.395
San Jose 1.166
Singapore 1.106
Lauterbourg 460
Ashburn 328
Ho Chi Minh City 245
New York 206
Beijing 196
Hanoi 176
Hong Kong 172
Helsinki 109
Bordighera 108
Santa Clara 108
Frankfurt am Main 83
Council Bluffs 75
Los Angeles 71
Zurich 66
Tokyo 65
Milan 52
Chicago 50
Mexico City 47
Haiphong 39
Da Nang 36
Dallas 36
Phoenix 34
Tianjin 33
Rome 29
Atlanta 23
Houston 23
Des Moines 22
Amsterdam 21
Buffalo 21
San José 21
Montreal 20
San Francisco 20
Toronto 20
Shanghai 17
Biên Hòa 16
Brooklyn 16
Philadelphia 16
Baghdad 15
City of London 15
Orem 15
Kingston 14
Washington 14
Naples 13
São Paulo 13
Bangkok 12
Dublin 12
Hải Dương 12
Miami 12
Ninh Bình 12
Queens 12
The Bronx 12
Cardiff 11
Columbus 11
Pittsburgh 11
Charlotte 10
Denver 10
Jacksonville 10
London 10
Mumbai 10
Princeton 10
Brasília 9
Florence 9
Guatemala City 9
Johannesburg 9
Palermo 9
San Salvador 9
Seattle 9
Tashkent 9
Can Tho 8
Dhaka 8
Jakarta 8
Managua 8
Medellín 8
Minneapolis 8
Valenza 8
Akron 7
Baltimore 7
Guangzhou 7
Guayaquil 7
Nairobi 7
Nashville 7
Newton 7
Paris 7
Amman 6
Boardman 6
Boston 6
Boydton 6
Catania 6
Chaguanas 6
Chennai 6
Cincinnati 6
Fresno 6
Hamilton 6
Hưng Yên 6
Totale 64.692
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 264
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 249
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 243
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 240
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 236
Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. 231
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 228
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 228
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. 220
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 220
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 220
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 217
2B4 functions as a co-receptor in human NK cell activation 216
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 216
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 213
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 208
NK/DC crosstalk in anti-viral response. 207
Bridging innate NK cell Functions with Adaptive Immunity. 206
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 206
Features of Memory-Like and PD-1+ Human NK Cell Subsets 205
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 205
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 205
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 203
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 198
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 198
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 196
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 195
X-linked lymphoproliferative disease: the dark side of 2B4 function. 194
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 193
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 192
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 192
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 192
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 191
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 191
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 191
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 190
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 189
Function and specificity of human natural killer cell receptors. 189
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 188
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 187
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 187
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 187
Markers and function of human NK cells in normal and pathological conditions 186
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 185
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 184
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 184
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 184
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 183
NK cells and their receptors during viral infections. 183
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 183
Human NK receptors: from the molecules to the therapy of high risk leukemias. 183
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 183
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 181
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 180
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 179
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 178
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 177
Multi-directional cross-regulation of NK cell function during innate immune responses. 176
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 176
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 176
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). 176
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 175
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 175
CIS is a negative regulator of IL-15-mediated signals in NK cells 175
Natural killer cells and dendritic cells: rendezvous in abused tissues. 174
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 174
Alloreactive natural killer cells in targeting high-risk leukaemias. 174
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 174
KIR and KIR ligand polymorphism: a new area for clinical applications? 174
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. 174
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 174
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 173
Human NK cells and NK receptors 173
A high-resolution view of NK-cell receptors: structure and function. 173
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 173
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 172
Stimulatory receptors in NK and T cells. 171
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 171
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 171
Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages 170
Cellular ligands for activating NK receptors 169
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 169
Impact of HCMV Infection on NK Cell Development and Function after HSCT. 169
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 169
Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). 169
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. 168
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 168
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 168
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 168
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 167
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. 166
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 166
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion 166
A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. 165
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 165
Unravelling natural killer cell function: triggering and inhibitory human NK receptors. 164
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. 164
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. 163
IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens. 162
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases. 162
Totale 18.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.637
article - articoli 187.969
book - libri 0
conference - conferenze 8.434
curatela - curatele 0
other - altro 0
patent - brevetti 12.718
selected - selezionate 0
volume - volumi 2.516
Totale 423.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.108 179 498 640 659 277 297 379 1.421 220 550 259 729
2022/20235.521 631 317 52 576 895 1.118 2 397 1.014 34 410 75
2023/20242.479 123 419 69 287 229 353 107 163 194 77 145 313
2024/20257.531 126 644 317 488 1.283 711 678 991 319 342 668 964
2025/202613.077 1.447 350 787 1.045 1.613 1.553 2.362 597 830 1.212 540 741
2026/20271.454 1.454 0 0 0 0 0 0 0 0 0 0 0
Totale 70.670